|
| |
Novo NordiskNovo Nordisk is a healthcare company and a world leader in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy.
Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society.
With headquarters in Denmark, Novo Nordisk employs approximately 23,600 full-time employees in 79 countries, and markets its products in 179 countries.
Novo Nordisk’s B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol ‘NVO’.
| Contact Details: |
| Novo Allé |
| Bagsværd |
| |
| 2880 |
| Denmark |
| Tel: | +45 4444 8888 |
| Fax: | +45 4449 0555 |
| Email: | |
| WWW: | www.novonordisk.com/
|
| |
Recent Publications by Novo Nordisk: |  |
Purification and characterization of a new recombinant factor VIII (N8).
Summary. A new recombinant factor VIII (FVIII), N8, has been produced in... | 13th November, 2009
| Biopharmaceutical Research Unit, Novo Nordisk A/S, Maaloev, Denmark.
| Haemophilia. 2009 Nov 11.
DOI Direct Link |
eggNOG v2.0: extending the evolutionary genealogy of genes with enhanced non-supervised orthologous groups, species and functional annotations.
The identification of orthologous relationships forms the basis for most... | 11th November, 2009
| European Molecular Biology Laboratory, Meyerhofstrasse 1, 69117
| Nucleic Acids Res. 2009 Nov 9.
DOI Direct Link |
Synchronization in G(0)/G (1) enhances the mitogenic response of cells overexpressing the human insulin receptor A isoform to insulin.
Evaluating mitogenic signaling specifically through the human insulin... | 10th November, 2009
| Insulin Biology, Novo Nordisk Park C9.S.27, 2760, Maaloev, Denmark,
| Cell Biol Toxicol. 2009 Nov 8.
DOI Direct Link |
STITCH 2: an interaction network database for small molecules and proteins.
Over the last years, the publicly available knowledge on interactions... | 10th November, 2009
| Biotechnology Center, TU Dresden, 01062 Dresden, Germany, Novo Nordisk
| Nucleic Acids Res. 2009 Nov 6.
DOI Direct Link |
High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression.
BACKGROUND: Egr-1 (early growth response-1 transcription factor) has been... | 3rd November, 2009
| Cell and Antibody Analysis, Novo Nordisk A/S, Novo Nordisk Park, DK-2760
| BMC Cancer. 2009 Oct 30;9:385.
DOI Direct Link |
→View more Novo Nordisk research publications. |
Press Releases on Novo Nordisk:
|
 |
| Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director |
23rd November, 2009 |
Immune Design Corp. |
SEATTLE, Nov. 23 /PRNewswire/ -- Immune Design Corp. (IDC) announced today that Dr. Bruce L.A. Carter has joined IDC as Executive Chairman. Dr. Carter has a successful track record in biotechnology
|
| Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show |
19th November, 2009 |
National Changing Diabetes Program |
Primary Care Doctors, Endocrinologists Feel Ill-Equipped to Provide Ideal, Multi-Disciplinary Team Care
PRINCETON, N.J., Nov. 19 /PRNewswire/ -- Nearly one-third of doctors surveyed said they did not
|
| Reportlinker Adds The Future of the Diabetes Care Devices Market to 2015 |
18th November, 2009 |
Reportlinker |
NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
The Future of the Diabetes Care Devices Market to 2015
http://www
|
| Pharmaceutical Employer Market Strategies: Influencing the Influencers |
12th November, 2009 |
Best Practices, LLC |
CHAPEL HILL, N.C., Nov. 12 /PRNewswire/ -- In an alternative and complementary approach to the current pharmaceutical commercial model, bio-pharmaceutical companies today are actively working to build
|
| Hypoglycemia Education - A Vital Weapon in the Battle to Conquer Diabetes |
12th November, 2009 |
ESP Bioscience |
LONDON, November 12 /PRNewswire/ -- The on-line journal Diabetic
Hypoglycemia (http://www.hypodiab.com/) supports the message of World
Diabetes Day 2009 (http://www.worlddiabetesday.org) in their
|
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 258 individuals from Novo Nordisk using this service.  Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 655 times since April 2007, the link to the organisation's website has been followed 82 times Recent Search Terms used to find this page: FDA Calendar Updates Novo Nordisk Eisai Acura King and Myriad | novo nordisk company profile | novo nordisk so macon ga | . Search for more companies in Bagsværd Search for more companies in This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Novo Nordisk |
